| Yoga Therapist | 01 | Yoga and Pranayama for Optimizing Quality of Life in Patients with Advanced Lung Cancer: A Multicenter Randomized Controlled Trial (YOGA LUNG TRIAL), Project A/c No. 160088 | Post Graduate Degree in Yoga/Yogic Science from a recognized university/institute
OR Graduate Degree in Yoga/Yogic Science from a recognized university/institute
OR Any other graduate degree + Diploma/Certificate course in Yoga from a recognized university/institute | PG Degree: ₹35,000 (Fresher), ₹38,000 (1 year), ₹41,000 (2 years), ₹44,000 (3 years)
Graduate Degree / Other Graduate + Diploma/Certificate: ₹30,000 (Fresher), ₹33,000 (1 year), ₹36,000 (2 years), ₹39,000 (3 years) | 45 years | 20.04.2026 |
| Clinical Research Monitor | 01 | Yoga and Pranayama for Optimizing Quality of Life in Patients with Advanced Lung Cancer: A Multicenter Randomized Controlled Trial (YOGA LUNG TRIAL), Project A/c No. 160088 | M.Sc. / M.Pharm with PG Diploma in Clinical Research mandatory
OR M.Sc. in Clinical Research
OR MBBS / BDS / BAMS / BHMS / BUMS with PG Diploma in Clinical Research mandatory
OR Pharm D
OR Equivalent qualification | M.Sc. / M.Pharm / M.Sc. in Clinical Research / Equivalent: ₹32,000 (Fresher), ₹34,000 (1 year), ₹36,000 (2 years), ₹38,000 (3 years), ₹40,000 (4 years)
MBBS / BDS / BAMS / BHMS / BUMS / Pharm D / Equivalent: ₹50,000 (Fresher), ₹55,000 (1 year), ₹60,000 (2 years), ₹65,000 (3 years), ₹70,000 (4 years) | 45 years | 22.04.2026 |
| Clinical Research Coordinator | 01 | A Multicentre randomized study of neoadjuvant systemic therapy in oral cavity cancer, Project A/c No. 160055 | B.Sc. / B.Pharm with PG Diploma in Clinical Research mandatory or equivalent qualification | ₹27,000 (Fresher), ₹29,000 (1 year relevant experience) | 45 years | 22.04.2026 |
| Clinical Research Coordinator | 01 | A phase IIIb, multi-center, open-label, randomized study of tolerability and efficacy of oral asciminib versus nilotinib in patients with newly diagnosed Philadelphia chromosome positive chronic Myelogenous Leukemia in Chronic Phase, Project A/c No. 9490 | B.Sc. / B.Pharm with PG Diploma in Clinical Research mandatory or equivalent qualification along with 1-year relevant experience | ₹29,000 | 45 years | 22.04.2026 |
| Research Nurse | 01 | A Randomized Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants with KRAS/NRAS and BRAF Wild-Type Unresectable or Metastatic Left Sided Colorectal Cancer, Project A/c No. 180024 | General Nursing & Midwifery (GNM) or B.Sc. Nursing
Candidate should be eligible to register with Indian Nursing Council / State Nursing Council
Hepatitis Vaccination should be completed | ₹32,000 (Fresher), ₹33,500 (1 year relevant experience) | 30 years | 22.04.2026 |
| Research Assistant | 01 | Academic Fund, Project A/c No. 9299 | Graduate degree in Science | ₹23,000 | 30 years | 23.04.2026 |
